Scientific Program

  • home
  • PROGRAM
  • Scientific Program

November 1 (Thu)

Symposium 01

The current status of healthcare-associated infection (HAI) and role of clinical microbiology

Overview:
This session will manage the current situation of healthcare-associated infections in Korea, especially from the point of view of carbapenem-producing Enterobacteriaecae, which is a notorious emerging threat in many countries, and the role of the clinical microbiology laboratory in overcoming the public threat will be discussed.
Date & Time Nov. 1 (Thu), 08:00-10:00 Venue Room B Language Korean
Speakers
  1. 1.Perspectives of HAIs from the Korean national healthcare-associated infection surveillance system
    Young Hwa Choi, Department of Infectious Diseases, Ajou University School of Medicine, Korea
  2. 2.The current status of carbapenem-resistant Enterobacteriacae in Korea: Vicious cycle between acute care hospitals and long term care facilities
    Hyungmin Lee, Division of Healthcare Associated Infection Control, Korea Centers for Disease Control and Prevention, Korea
  3. 3.Impact of rapid surveillance of CPE and preemptive isolation on CPE prevention and control
    Taek Soo Kim, Seoul National University Hospital, Korea
  4. 4.Changing role of clinical microbiology in HAI prevention and control
    Hyukmin Lee, Yonsei University College of Medicine, Korea

Symposium 02

Inspector workshop of Korean laboratory accreditation program

Overview:
This workshop deals with the accreditation checklist and intends to improve understanding and practical skills required of inspection team leaders and members.
Date & Time Nov. 1 (Thu), 10:00-12:00 Venue Room B Language Korean
Speakers
  1. 1.Quality control program of point-of-care testing
    Jinsook Lim, Chungnam National University Hospital, Korea
  2. 2.Korean laboratory accreditation program (KLAP): What laboratory director and inspection team leader should know & risk management in clinical laboratories
    Woo-In Lee, Kyung Hee University School of Medicine, Korea
  3. 3.Inspection points during laboratory results reporting process
    Sang-Guk Lee, Yonsei University College of Medicine, Korea
  4. 4.Internal quality control program of viral serological assay
    Hyun Soo Kim, Hallym University College of Medicine, Korea

Symposium 03

Education course for laboratory medicine specialist

Overview:
This session has been organized to provide specialists a chance for continuing education in the department of laboratory medicine, including diagnostic hematology, clinical chemistry, diagnostic immunology, clinical microbiology, transfusion medicine, and diagnostic genetics. This program is operated under Korean Medical law and will introduce the current issues of each sub-specialty regarding clinical practices and resident training.
Date & Time Nov. 1 (Thu), 13:00-17:00 Venue Room B Language Korean
Speakers
  1. 1.Current issues in diagnostic hematology
    Jaewoo Song, Yonsei University College of Medicine, Korea
  2. 2.Guideline for resident training in diagnostic hematology
    Ajin Lee, Catholic University of Daegu College of Medicine, Korea
  3. 3.Current issues in clinical chemistry
    Sang-Guk Lee, Yonsei University College of Medicine, Korea
  4. 4.Guideline for resident training in clinical chemistry
    Hyungdoo Park, Sungkyunkwan University School of Medicine, Korea
  5. 5.Current issues in diagnostic immunology
    Eun-Suk Kang, Sungkyunkwan University School of Medicine, Korea
  6. 6.Guideline for resident training in diagnostic immunology
    Yongjung Park, Korea National Health Insurance Service Ilsan Hospital, Korea
  7. 7.Current issues in clinical microbiology
    Kyoung Un Park, Seoul National University Bundang Hospital, Korea
  8. 8.Guideline for resident training in clinical microbiology
    Jae-Hyun Lee, Chonbuk National University Medical School, Korea
  9. 9.Current issues in transfusion medicine
    Soyong Kwon, Korean Red Cross, Korea
  10. 10.Guideline for resident training in transfusion medicine
    Chunhwa Ihm, Eulji University Hospital, Korea
  11. 11.Current issues in diagnostic genetics
    Ja Young Seo, Gachon University Gil Medical Center, Korea
  12. 12.Guideline for resident training in diagnostic genetics
    Minjung Kwon, Sungkyunkwan University School of Medicine, Korea
  13. 13.Current issues in medical ethics
    Ilhak Lee, Yonsei University College of Medicine, Korea
  14. 14.Current guideline for specialty qualification examination in laboratory medicine
    Myung-Geun Shin, Chonnam National University Medical School, Korea

Symposium 04: Joint Workshop with Ministry of Food and Drug Safety (MFDS) and KSLM
Industry-Academia-Government (IAG) Committee:

In vitro diagnostics device registration and modification for MFDS

Overview:
To share the MFDS registration experience in IVD trials and report to MFDS for a minor change of IVD, this workshop, organized by the KSLM IAG committee and MFDS, will help principal investigators (PI) and IVD developers understand the process of registering and minor change reports to MFDS for IVD.
Date & Time Nov. 1 (Thu), 15:00-17:00 Venue Room C Language Korean
Speakers
  1. 1.Development of a hand of applicants for change of permission based on the negative list system for in vitro diagnostics
    Eun-Jee Oh, The Catholic University of Korea, College of Medicine, Korea
  2. 2.TBD
    Hye Kyung Chung, Synex, Korea
  3. 3.TBD
    TBD

Plenary Lecture 01

Date & Time Nov. 1 (Thu), 17:30-18:30 Venue Walkerhill Theatre Language English
Speaker
  • Blood type and personality – Asian mythology
    Kyou-Sup Han, Seoul National University College of Medicine, Korea

November 2 (Fri)

Keynote Speech 01

Date & Time Nov. 2 (Fri), 08:00-08:40 Venue Room A Language English
Speaker
  • Clinical pathologists and taking care of patients in the clinic
    Seongsoo Jang, University of Ulsan College of Medicine, Korea

Symposium 05

Statistics & ethics for laboratory researches

Overview:
TBD
Date & Time Nov. 2 (Fri), 08:40-10:40 Venue Room A Language English
Speakers
  1. 1.Using the R programming language for method validation
    Daniel T. Holmes, St. Paul’s Hospital, Canada
  2. 2.Making sense of statistics for laboratory medicine
    Shuji Ogino, Harvard Medical School, USA
  3. 3.Publication ethics for authors
    Soo Young Kim, Department of Family Medicine, Hallym University Medical College, Korea

Symposium 06

Clinical laboratory reimbursement – Financial aspects of laboratory medicine

Overview:
TBD
Date & Time Nov. 2 (Fri), 08:00-10:30 Venue Room B Language English
Speakers
  1. 1.Financial aspects of laboratory medicine in India
    Praveen Sharma, All India Institute of Medical Sciences, India
  2. 2.Laboratory test reimbursement policies in Japanese health insurance systems; Against cost-cut pressure
    Taiji Furukawa, Teikyo University School of Medicine, Japan
  3. 3.Clinical laboratory reimbursement in tertiary hospital in Indonesia
    Nina Susana Dewi, Padjadjaran University Bandung, Indonesia
  4. 4.Financial aspects of laboratory medicine in Mongolia
    Oyundelger Munkhtuvshin Ertsuud, Mongolian Association of the Laboratory Medicine, Mongolia
  5. 5.Financial aspects of laboratory medicine in Malaysia
    Lai-Meng Looi, University of Malaya, Malaysia
  6. 6.Clinical laboratory reimbursement – Financial aspects of laboratory medicine in Thailand
    Nisarat Opartkiattikul, Thai Society of Clinical Pathology, Thailand
  7. 7.Financial aspects of laboratory medicine in public medical units in Vietnam
    Dr. Nguyen Minh Ha, Nguyen Tri Phuong Hospital, Vietnam
  8. 8.Financial aspect of medical laboratories in Myanmar
    Dr. Wah Wah Aung, Ministry of Health and Sports, Myanmar
  9. 9.Health insurance reimbursement system in Korea
    Tae Hyun Um, Inje University Ilsan Paik Hospital, Korea

Symposium 07

New molecular technologies for personalized medicine

Overview:
Advances in molecular technologies are expanding the scope of personalized medicine, a tailoring of medical treatment based on an individual's genetic profile, especially in the field of medical oncology. Topics to be presented in this session will focus on the development and clinical applications of new molecular technologies that drive personalized and precision medicine.
Date & Time Nov. 2 (Fri), 09:00-10:40 Venue Room C Language English
Speakers
  1. 1.Analysis and clinical applications Exosome for liquid biopsy of cancer
    Lei Zheng, Southern Medical University, China
  2. 2.Application of BEAMing technology for circulating tumor DNA detection
    Myungshin Kim, The Catholic University of Korea College of Medicine, Korea
  3. 3.The current and future of circulating tumor DNA sequencing in precision oncology
    Young Kwang Chae, Northwestern University Feinberg School of Medicine, USA

Plenary Lecture 02

Date & Time Nov. 2 (Fri), 11:00-12:00 Venue Room A Language English
Speaker
  • Expanding the measurable metabolome: How should we mine the lipidome?
    Dennis J. Dietzen, Washington University School of Medicine, USA

Education Workshop 01

Review on potential biotin interference in diagnostic assays

Date & Time Nov. 2 (Fri), 12:00-13:00 Venue Room A Language English
Speakers
  1. 1.Review on potential biotin interference in diagnostic assays
    Hai Young Jung, North Asia Abbott Diagnostic Division, Korea

Education Workshop 04

Significance of full panel assays in syndromic diagnosis for infectious diseases

Date & Time Nov. 2 (Fri), 12:00-13:00 Venue Room D Language English
Speakers
  1. 1.Significance of full panel assays in syndromic diagnosis for infectious diseases
    TBD

Symposium 08

Practical aspects of the laboratory management Ⅳ; Laboratory Information System (LIS) & Information Communication Technology (ICT)

Overview:
The ‘Laboratory Management Committee’ will introduce the Basic Principles of the Laboratory Information System (LIS), Maximizing the Value of Test Results with Information Communication Technology (ICT), and Middle Ware Applications & ICT, which are essential elements for effective laboratory management.
Date & Time Nov. 2 (Fri), 13:00-14:40 Venue Room A Language English
Speakers
  1. 1.Basic principle of LIS
    Je Hoon Lee, The Catholic University of Korea Yeouido St. Mary's Hospital, Korea
  2. 2.Using the R statistical programming language for quality improvement and monitoring
    Janet Simons, St. Paul’s Hospital, Canada
  3. 3.Maximizing the value of test results with ICT
    Won-Ki Min, University of Ulsan College of Medicine, Korea
  4. 4.Middle ware applications and ICT
    Hyung Hoi Kim, Pusan National University Hospital, Korea

Symposium 09

Education track I

Overview:
According to the revised eligibility criteria policy, the specialized education of each division will be needed in addition to common education course. Therefore, this session aims to admitted professional qualities required as an educational supervisor and a resident in training and to improve the problem solving capabilities when working in the laboratory. In this session, we will go over for the updated laboratory diagnosis in the fields of immunology, microbiology and genetics.
Date & Time Nov. 2 (Fri), 13:00-14:40 Venue Room B Language English
Speakers
  1. 1.Updates on laboratory diagnosis of HIV infection
    Younhee Park, Yonsei University College of Medicine, Korea
  2. 2.Application of rapid molecular diagnostic method for Tuberculosis
    Chang Ki Kim, Seoul Clinical Laboratories, Korea
  3. 3.Microbial laboratory tests using matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)
    Jeong Su Park, Seoul National University Bundang Hospital, Korea
  4. 4.Clinical principles and applications of molecular genetic testing
    Seung-Tae Lee, Yonsei University College of Medicine, Korea

Symposium 10

Genomics of human leukocyte antigen (HLA) in next generation sequencing (NGS) era

Overview:
We would like to share the recent application of NGS technology in HLA genomics, particularly related with disease association and transplantation.
Date & Time Nov. 2 (Fri), 13:00-14:40 Venue Room C Language English
Speakers
  1. 1.The 17th international HLA and immunogenetics workshop: Advances in NGS for studying HLA
    Steven J. Mack, The UCSF School of Medicine, USA
  2. 2.HLA genomics in the field of disease association
    Katsushi Tokunaga, University of Tokyo Graduate School of Medicine, Japan
  3. 3.Role of HLA-DP in HBV vaccine response
    Soie Chung, Seoul National University Hospital Healthcare System Gangnam Center, Korea

Symposium 11

Accreditation system for clinical laboratory

Overview:
TBD
Date & Time Nov. 2 (Fri), 15:00-17:00 Venue Room A Language English
Speakers
  1. 1.TBD
    Ryan Robetorye, Mayo Clinic, USA
  2. 2.Accreditation as a driver of quality improvement and patient-centeredness
    Carsten Engel,Danish Institute for Quality and Accreditation in Healthcare (IKAS), Denmark
  3. 3.LMF accreditation & ISO 15189
    Wee Gyo Lee, Ajou University School of Medicine, Korea

Symposium 12

Education track 2

Overview:
According to the revised eligibility criteria policy, specialized education for each division will be needed in addition to general education courses. Therefore, this session aims at the professional qualities required as an educational supervisor and resident in training and to improve the problem-solving capabilities when working in the laboratory. The special divisions covered in this session are clinical chemistry, diagnostic hematology, transfusion medicine, and clinical microbiology and will give us the latest practical information.
Date & Time Nov. 2 (Fri), 15:00-16:40 Venue Room B Language English
Speakers
  1. 1.Interpretation of quality control in clinical chemistry
    Kyunghoon Lee, Seoul National University Bundang Hospital, Korea
  2. 2.Molecular genetic tests of hematologic malignancy
    Mi-Ae Jang, Soonchunhyang University College of Medicine, Korea
  3. 3.ABO discrepancies and RhD variants
    Duck Cho, Sungkyunkwan University School of Medicine, Korea
  4. 4.Evolution of antimicrobial resistance in Neisseria gonorrhoeae
    Hyukmin Lee, Yonsei University College of Medicine, Korea

Symposium 13: AACC-KSLM Select Session

Emerging clinical applications of circulating DNA analysis

Overview:
Much recent progress has been achieved in the analysis of circulating graft-derived and tumor-derived DNA. Some of these new applications have been or will soon be implemented clinically for organ transplantation monitoring and cancer screening/diagnosis. In this session, details of clinical studies, technological and molecular approaches as well as new biological understanding of circulating DNA will be shared.
Date & Time Nov. 2 (Fri), 15:00-16:40 Venue Room C Language English
Speakers
  1. 1.Cancer screening by circulating tumor DNA analysis is becoming a clinical reality
    Jacky Lam, The Chinese University of Hong Kong, Hong Kong
  2. 2.Graft-derived cell-free DNA – A promising noninvasive marker for detection of rejection and graft injury after solid organ transplantation
    Michael Oellerich, George-August University, Germany
  3. 3.The external quality assessment (EQA) program for circulating tumor DNA analysis: Status quo and prospects
    Woochang Lee, University of Ulsan College of Medicine, Korea

Keynote Speech 02

Date & Time Nov. 2 (Fri), 17:00-17:40 Venue Room A Language English
Speaker
  • Strategies to optimize medical laboratory for patient care in the era of universal coverage
    Lia G Partakusuma, National Cardiovascular Centre Harapan Kita Jakarta, Indonesia

November 3 (Sat)

Keynote Speech 03

Date & Time Nov. 3 (Sat), 08:00-08:40 Venue Room A Language English
Speaker
  • Bioactive lipids in laboratory medicine
    Yutaka Yatomi, The University of Tokyo Graduate School of Medicine, Japan

Symposium 14

Customer focused documents of CLSI

Overview:
TBD
Date & Time Nov. 3 (Sat), 09:00-10:40 Venue Room A Language English
Speakers
  1. 1.CLSI document QMS19-Customer focus in a quality management system
    Carl D. Mottram,Mayo Clinic College of Medicine, USA
  2. 2.CLSI document GP45-Studies to evaluate patient outcomes
    James H. Nichols, Vanderbilt University School of Medicine, USA
  3. 3.Developing and managing a medical laboratory (test) utilization management program
    Sollip Kim, Inje University Ilsan Paik Hospital, Korea

Symposium 15

Recent trends in clinical chemistry for optimal patients care

Overview:
A hormone is a chemical substance produced in the body by an organ, cells of an organ, or scattered cells, having a specific regulatory effect on the activity of organs. For optimal patient care, accurate and specific measurement of hormones such as vitamin D, thyroid hormones, and testosterone, is important. These hormones are measured by a variety of analytical techniques, including bioassay, immunoassay, and mass spectrometry interfaced with liquid chromatography. In this section, we will provide useful information about the analytical details for individual hormones using such techniques and clinical implications of these hormones assays.
Date & Time Nov. 3 (Sat), 09:00-10:40 Venue Room B Language English
Speakers
  1. 1.Critical levels of serum 25-Hydroxyvitamin D for metabolic bone disease
    Howard Morris, University of South Australia, Australia
  2. 2.Cannabinoids in California-approach to assessing driving under the influence
    Robert L. Fitzgerald, University of California-San Diego, USA
  3. 3.Optiumu utilization of automated urine microscopy
    Jeong-Ho Kim, Yonsei University College of Medicine, Korea
  4. 4.The significance of chitotriosidase determination in the diagnosis of inborn errors of metabolism
    Yoon Shin-Podskarbi, Ludwig Maximilian University of Munich, Germany

Symposium 16

Updates in laboratory hematology

Overview:
In every discipline of laboratory hematology, we are continuously confronting challenges as the understanding of diseases and clinical practices improve and evolve. Essential and inspiring updates in diverse fields covered here will help to stimulate research in laboratory hematology and make clinical services more complete.
Date & Time Nov. 3 (Sat), 09:00-10:40 Venue Room C Language English
Speakers
  1. 1.Flow cytometry for acute leukemia diagnosis and classification
    Chan-Jeoung Park, University of Ulsan College of Medicine, Korea
  2. 2.Clot wave form analysis, laboratory monitoring of bleeding in hemophilia
    Midori Shima, Nara Medical University, Japan
  3. 3.Update on the pathogenesis and laboratory diagnosis of thrombotic thrombocytopenic purpura
    Ross I. Baker, Murdoch University, Australia

Symposium 17: KCDC-KSLM Session

Legislation for diagnostic tests: National regulation or supports

Overview:
Enactment and support of legislation is required to perform appropriate diagnostic tests and strengthen the capacity of the laboratory. In Korea, the area of clinical laboratory testing has continuously expanded over time and proper legislation for the clinical laboratory is needed. In this session, the results of the research project for legislation for the clinical laboratory, which was performed by the Korea Legislation Research Institute with the cooperation of the KSLM, is going to be presented and the results will be discussed by experts to the public.
Date & Time Nov. 3 (Sat), 09:00-10:40 Venue Room D Language Korean

Plenary Lecture 03

Date & Time Nov. 3 (Sat), 11:00-12:00 Venue Room A Language English
Speaker
  • The fight against antimicrobial resistance: Are we doing right?
    Jesús Rodríguez Baño, University of Sevilla, Spain

Education Workshop 07

Next generation of prostate cancer diagnosis – Clinical utility of phi

Date & Time Nov. 3 (Sat), 12:00-13:00 Venue Room A Language English
Speakers
  1. 1.Next generation of prostate cancer diagnosis – Clinical utility of phi
    TBD

Education Workshop 09

Actual state of HbA1c measurement in Japan

Date & Time Nov. 3 (Sat), 12:00-13:00 Venue Room C Language English
Speakers
  1. 1.Actual state of HbA1c measurement in Japan
    Asako Sato, Tokyo Women's Medical University Hospital, Japan

Keynote Speech 04

Date & Time Nov. 3 (Sat), 13:00-13:40 Venue Room A Language English
Speaker
  • Integrative microbiology & immunology-MPE (Molecular Pathological Epidemiology)
    Shuji Ogino, Harvard Medical School, USA

Symposium 18

Precision medicine in infectious diseases

Overview:
Precision medicine in infectious diseases
Date & Time Nov. 3 (Sat), 14:00-15:30 Venue Room A Language English
Speakers
  1. 1.The coming era of precision medicine in infectious diseases
    Jesús Rodríguez Baño, University of Sevilla, Spain
  2. 2.Next generation sequencing in routine clinical microbiology
    John Rossen, University of Groningen, The Netherlands
  3. 3.Multiplex identification of major sepsis-Causing pathogens from the plasma of infected blood
    Yeun-Jun Chung, Department of Microbiology, The Catholic University of Korea College of Medicine, Korea

Symposium 19

Guidelines of clinical tests for patients care

Overview:
TBD
Date & Time Nov. 3 (Sat), 14:00-15:40 Venue Room B Language English
Speakers
  1. 1.Chronic renal failure biomarker
    Graham Jones, St Vincent’s Pathology in Sydney, Australia
  2. 2.Biomarkers of diabetes
    Philippe Gillery, Secteur Biochimie, Pôle de Biologie Médicale et Pathologie, France
  3. 3.Guideline for protein electrophoresis tests for patient care
    Dr. Helen Martin, Healthscope Pathology, Australia
  4. 4.Next generation sequencing-based gene panel and exome testing
    Chang-Seok Ki, Green Cross Genome, Korea

Symposium 20

Role of specialist in transfusion medicine

Overview:
People with specialized expertise in the field of transfusion medicine play many roles in the modern hospital setting. This session will look at a variety of activities that are performed by these experts so that patients can receive transfusion support that meets the high standards required nowadays.
Date & Time Nov. 3 (Sat), 14:00-15:30 Venue Room C Language English
Speakers
  1. 1.The role of the transfusion practitioner as a specialist in transfusion medicine
    Rachel Moss, Great Ormond Street Hospital for Children NHS Foundation Trust, UK
  2. 2.Support of blood banks for surgery
    David Roxby, Flinders Medical Centre, Australia
  3. 3.A consultant for clinicians
    Sejong Chun, Chonnam National University Medical School, Korea